These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 1677232)

  • 21. [Schizophrenic deficit syndrome and neurologic tolerance].
    Verdoux H; Bourgeois M
    Encephale; 1996 Jun; 22 Spec No 2():45-7. PubMed ID: 8767042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-induced parkinsonism: relationship to age at onset of schizophrenia.
    Sandyk R; Kay SR
    Funct Neurol; 1991; 6(2):151-7. PubMed ID: 1680777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pseudoakathisia and negative symptoms in schizophrenic subjects.
    Brown KW; White T
    Acta Psychiatr Scand; 1991 Jul; 84(1):107-9. PubMed ID: 1681679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Akathisia: a distressing complication of neuroleptic treatment.
    Szabadi E
    Compr Ther; 1987 Sep; 13(9):3-6. PubMed ID: 2889560
    [No Abstract]   [Full Text] [Related]  

  • 25. Comment on "tardive dyskinesia circa 2006".
    Rosenheck RA
    Am J Psychiatry; 2007 Jan; 164(1):170; author reply 170. PubMed ID: 17202564
    [No Abstract]   [Full Text] [Related]  

  • 26. Catatonia and other motor syndromes in a chronically hospitalized psychiatric population.
    Bush G; Petrides G; Francis A
    Schizophr Res; 1997 Oct; 27(1):83-92. PubMed ID: 9373898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia.
    Barnes TR
    Psychiatr Dev; 1987; 5(4):301-19. PubMed ID: 2895467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of extrapyramidal side effects with terguride.
    Filip V; Marsálek M; Hálková E; Karen P
    Psychiatry Res; 1992 Jan; 41(1):9-16. PubMed ID: 1348584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Akathisia, pseudoakathisia and tardive dyskinesia: clinical examples.
    Munetz MR; Cornes CL
    Compr Psychiatry; 1982; 23(4):345-52. PubMed ID: 6126315
    [No Abstract]   [Full Text] [Related]  

  • 30. Akathisia: prevalence and associated dysphoria in an in-patient population with chronic schizophrenia.
    Halstead SM; Barnes TR; Speller JC
    Br J Psychiatry; 1994 Feb; 164(2):177-83. PubMed ID: 7909711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of manual dominance in patients with neuroleptic-induced movement disorders.
    Kern RS; Green MF; Satz P; Wirshing WC
    Biol Psychiatry; 1991 Sep; 30(5):483-92. PubMed ID: 1681944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication.
    Glazer WM; Morgenstern H; Schooler N; Berkman CS; Moore DC
    Br J Psychiatry; 1990 Oct; 157():585-92. PubMed ID: 1983390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Schizophrenia and severe tardive dyskinesia responsive to risperidone.
    Kopala LC; Honer WG
    J Clin Psychopharmacol; 1994 Dec; 14(6):430-1. PubMed ID: 7533794
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum iron and transferrin in acute neuroleptic induced akathisia.
    O'Loughlin V; Dickie AC; Ebmeier KP
    J Neurol Neurosurg Psychiatry; 1991 Apr; 54(4):363-4. PubMed ID: 1676049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Movement disorder in never and minimally treated Nigerian schizophrenic patients.
    McCreadie RG; Ohaeri JU
    Br J Psychiatry; 1994 Feb; 164(2):184-9. PubMed ID: 7909712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
    Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn AD
    Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A longitudinal study of correlations among tardive dyskinesia, drug-induced parkinsonism, and psychosis.
    Hansen TE; Weigel RM; Brown WL; Hoffman WF; Casey DE
    J Neuropsychiatry Clin Neurosci; 1992; 4(1):29-35. PubMed ID: 1352714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clozapine-induced tardive dyskinesia and hypothyroidism.
    Mendhekar DN; Duggal HS
    J Neuropsychiatry Clin Neurosci; 2006; 18(2):245-6. PubMed ID: 16720805
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
    Andrew HG
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: the Curaçao Extrapyramidal Syndromes Study II.
    van Harten PN; Hoek HW; Matroos GE; Koeter M; Kahn RS
    Schizophr Res; 1997 Aug; 26(2-3):235-42. PubMed ID: 9323356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.